Browsing Fisiología Médica y Biofísica by Subject "Daratumumab"
Now showing items 1-1 of 1
-
Article
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
(Nature Publishing Group, 2021)Multiple myeloma (MM) is incurable, so there is a significant unmet need for effective therapy for patients with relapsed ...